pubmed.ncbi.nlm.nih.gov

Epibatidine, an alkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent - PubMed

Affiliations

PMID: 8071862

Epibatidine, an alkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent

M Fisher et al. J Pharmacol Exp Ther. 1994 Aug.

Abstract

Epibatidine, a newly discovered alkaloid from the skin of Dendrobatidae frogs, has structural similarities to nicotine. We examined the effects of epibatidine on cardiorespiratory function and ganglionic synaptic transmission. Superior cervical or splanchnic sympathetic nerve discharge (sSND) and phrenic nerve discharge (PND) were recorded along with arterial pressure (AP) in urethane-anesthetized, paralyzed and artificially ventilated rats. Epibatidine administered i.v. at low doses (0.5-2 micrograms/kg) produced a transient increase in AP and sSND, followed by a decrease and return to baseline; this low dose of epibatidine also produced a dose-dependent increase in PND. At high doses (cumulative dose of 8-16 micrograms/kg), epibatidine produced bradycardia, a profound depression in sSND and a transient elimination of PND. After i.v. administration of the ganglionic blocker chlorisondamine (5 mg/kg), AP was still increased by 1 microgram/kg epibatidine (+39 +/- 11 mm Hg). This pressor effect was not altered by pretreatment with the alpha-1 adrenergic antagonist phentolamine (+40 +/- 10 mm Hg); however, it was blocked by additional pretreatment with the vasopressin antagonist [beta-mercapto-beta,beta-cyclopentamethylenepropiony1, O-ET-Tyr2,Val4,Arg8]vasopressin (50 micrograms/kg i.v.; +2 +/- 0.4 mm Hg). Low doses of epibatidine (0.5-2 micrograms/kg) produced firing of postganglionic neurons in a decentralized ganglion preparation and potentiated synaptic transmission; at high doses (cumulative dose of 8-16 micrograms/kg), the alkaloid blocked ganglionic synaptic transmission. These results suggest that epibatidine is a potent agonist of ganglionic nicotinic receptors and that the alkaloid elicits cardiorespiratory effects similar to those of nicotine.

PubMed Disclaimer

Cited by

Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
Fitch RW, Snider BB, Zhou Q, Foxman BM, Pandya AA, Yakel JL, Olson TT, Al-Muhtasib N, Xiao Y, Welch KD, Panter KE. Fitch RW, et al. J Nat Prod. 2018 Apr 27;81(4):1029-1035. doi: 10.1021/acs.jnatprod.8b00062. Epub 2018 Apr 19. J Nat Prod. 2018. PMID: 29671588 Free PMC article.
Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography.
Horti AG, Gao Y, Kuwabara H, Dannals RF. Horti AG, et al. Life Sci. 2010 Apr 10;86(15-16):575-84. doi: 10.1016/j.lfs.2009.02.029. Epub 2009 Mar 18. Life Sci. 2010. PMID: 19303028 Free PMC article. Review.
Alpha3beta4-nicotinic receptors mediate adrenergic nerve- and peptidergic (CGRP) nerve-dependent vasodilation induced by nicotine in rat mesenteric arteries.
Eguchi S, Miyashita S, Kitamura Y, Kawasaki H. Eguchi S, et al. Br J Pharmacol. 2007 Aug;151(8):1216-23. doi: 10.1038/sj.bjp.0707331. Epub 2007 Jun 18. Br J Pharmacol. 2007. PMID: 17572697 Free PMC article.
Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers.
Lotfipour S, Mandelkern M, Brody AL. Lotfipour S, et al. Curr Med Imaging Rev. 2011 May 1;7(2):107-112. doi: 10.2174/157340511795445676. Curr Med Imaging Rev. 2011. PMID: 22773924 Free PMC article.
Nanoparticle-conjugated animal venom-toxins and their possible therapeutic potential.
Biswas A, Gomes A, Sengupta J, Datta P, Singha S, Dasgupta AK, Gomes A. Biswas A, et al. J Venom Res. 2012;3:15-21. Epub 2012 Oct 23. J Venom Res. 2012. PMID: 23236583 Free PMC article.

Epibatidine, an alkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent - PubMed